Health and Fitness Health and Fitness
Mon, March 12, 2012
[ Mon, Mar 12th 2012 ] - Market Wire
Threshold Pharmaceuticals' TH-302 to Be Featured .. Cancer Hosted by the New York Academy of Sciences
[ Mon, Mar 12th 2012 ] - Market Wire
ONSOLIS Relaunch Postponed Pending Product Modification
[ Mon, Mar 12th 2012 ] - Market Wire
Given Imaging Announces Publication of Colon Capsule Endoscopy Guidelines in Endoscopy
[ Mon, Mar 12th 2012 ] - Market Wire
Teleflex Appoints Thomas E. Powell Senior Vice President & Chief Financial Officer
[ Mon, Mar 12th 2012 ] - Market Wire
PAREXEL Experts to Address Approaches to Accelera .. ase Development Decisions at ASCPT Annual Meeting
[ Mon, Mar 12th 2012 ] - Market Wire
Medisafe 1 Technologies Signs Marketing and Distribution Agreement with Health Product Carrier
[ Mon, Mar 12th 2012 ] - Market Wire
Sunshine Heart Provides FAQ Regarding Transmutation of CDIs to Common Stock
Sat, March 10, 2012
[ Sat, Mar 10th 2012 ] - Market Wire
Gegevens tonen aan dat Gilead';;s .. ferieur is aan op protease gebaseerd regime na 48
[ Sat, Mar 10th 2012 ] - Market Wire
I dati di un secondo importante studio di Fase II .. t del regime Quad di Gilead per il trattamento de
[ Sat, Mar 10th 2012 ] - Market Wire
Quad-HIV-Prparat von Gilead nach 48 Wochen nicht .. g auf Protease-Basis: Beleg durch Daten einer zwe
[ Sat, Mar 10th 2012 ] - Market Wire
Los datos muestran que el rgimen Quad de Gilead p .. rgimen basado en proteasa a las 48 semanas en un
[ Sat, Mar 10th 2012 ] - Market Wire
Gegevens tonen aan dat Gilead's Quad-regime voor .. protease gebaseerd regime na 48 weken, in tweede
[ Sat, Mar 10th 2012 ] - Market Wire
Tenet to Speak at the Barclays Capital Healthcare Conference on March 14th
[ Sat, Mar 10th 2012 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Lead Plain .. e In The Class Action Lawsuit Against TranS1 Inc.
Fri, March 9, 2012
[ Fri, Mar 09th 2012 ] - Market Wire
Edwards Lifesciences to Present at the 24th Annual ROTH Conference
[ Fri, Mar 09th 2012 ] - Market Wire
Cynapsus Therapeutics Announces $1 Million Financing
[ Fri, Mar 09th 2012 ] - Market Wire
Patient Home Monitoring (PHM) Announces February .. s and Growth Figures, Change in Operation Executi
[ Fri, Mar 09th 2012 ] - Market Wire
The Law Firm of Levi amp;; Korsinsky, LLP .. anscend Services, Inc. in Connection with the Sal
[ Fri, Mar 09th 2012 ] - Market Wire
Titan Medical Inc. Files Prospectus Supplement for Unit Offering
[ Fri, Mar 09th 2012 ] - Market Wire
Regeneron Announces Change in Date for Presentati .. arclays Capital 2012 Global Healthcare Conference
[ Fri, Mar 09th 2012 ] - Market Wire
Is Health Discovery Corporation Finally on the Verge of a Turnaround?
[ Fri, Mar 09th 2012 ] - Market Wire
Sequenom, Genworth Financial, Huntsman, New Gold, Huntington Bancshares, and Amarin
[ Fri, Mar 09th 2012 ] - Market Wire
Cantel Medical Corp. to Present at the Sidoti amp .. nth Annual Emerging Growth Institutional Investor
[ Fri, Mar 09th 2012 ] - Market Wire
(NYSE Amex: DXR) Daxor Announces Filing of Two Ad .. onal Patents for Updated Automated Blood Analyzer
[ Fri, Mar 09th 2012 ] - Market Wire
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on PhotoMedex, Inc.
[ Fri, Mar 09th 2012 ] - Market Wire
Ardea Biosciences Reports Recent Accomplishments .. urth Quarter and Full-Year 2011 Financial Results
[ Fri, Mar 09th 2012 ] - Market Wire
BD to Present at the Barclays Capital Global Healthcare Conference
[ Fri, Mar 09th 2012 ] - Market Wire
Equity Research on Valeant Pharmaceuticals Intern .. n Corp. plc - Drug Delivery Companies Up and Down
[ Fri, Mar 09th 2012 ] - Market Wire
Peregrine Reports Data From Phase II Front-Line Lung Cancer Trial
[ Fri, Mar 09th 2012 ] - Market Wire
Haemonetics Sets Date for Investor/Analyst Meeting
[ Fri, Mar 09th 2012 ] - Market Wire
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2011 Financial Results
[ Fri, Mar 09th 2012 ] - Market Wire
EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results
[ Fri, Mar 09th 2012 ] - Market Wire
Halozyme Reports Fourth Quarter and Year End 2011 Financial Results and Provides Guidance for 2012
[ Fri, Mar 09th 2012 ] - Market Wire
Delcath Selects Quintiles to Support EU Launch of CHEMOSAT
Thu, March 8, 2012
[ Thu, Mar 08th 2012 ] - Market Wire
Boston Scientific to Acquire Cameron Health, Inc.
[ Thu, Mar 08th 2012 ] - Market Wire
BIOLASE Chief Executive Officer to Continue at Rate of $1.00 Annual Salary
[ Thu, Mar 08th 2012 ] - Market Wire
PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million
[ Thu, Mar 08th 2012 ] - Market Wire
OncoGenex Pharmaceuticals, Inc. Reports Financial .. and Year End 2011 and Provides Update on Clinical
[ Thu, Mar 08th 2012 ] - Market Wire
Sangamo Presents New Clinical Data at CROI 2012 D .. ive Effects of ZFN Therapeutic for "Functional Cu
[ Thu, Mar 08th 2012 ] - Market Wire
Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance
[ Thu, Mar 08th 2012 ] - Market Wire
LED Dental Launches Second Step Laboratory Services in Canada
[ Thu, Mar 08th 2012 ] - Market Wire
Amylin Pharmaceuticals Announces Pricing of Public Offering of Common Stock
[ Thu, Mar 08th 2012 ] - Market Wire
USANA Health Sciences Unveils New Charitable Foundation
[ Thu, Mar 08th 2012 ] - Market Wire
MIT Agrees to $3.2 Million in Financing, Includin .. in Convertible Debentures and $1.2 Million in Deb
[ Thu, Mar 08th 2012 ] - Market Wire
Celsion Corporation to Hold Year-End 2011 Financi .. sults Conference Call on Thursday, March 15, 2012
[ Thu, Mar 08th 2012 ] - Market Wire
Palatin Technologies Completes Enrollment in Phas .. 2B Bremelanotide Female Sexual Dysfunction Trial
[ Thu, Mar 08th 2012 ] - Market Wire
Michael E. DeBakey VA Medical Center Initiates Ph .. ia with Aeterna Zentaris' Ghrelin Agonist, AEZS-1
[ Thu, Mar 08th 2012 ] - Market Wire
Isis Pharmaceuticals to Present at the Barclays Capital 2012 Global Healthcare Conference
[ Thu, Mar 08th 2012 ] - Market Wire
Implant Sciences Sells More QS-H150 Explosives Trace Detection Devices to Chinese Airports
[ Thu, Mar 08th 2012 ] - Market Wire
OncoSec to Evaluate Potential Predictive or Progn .. t of Solid Tumor Cancers Using OMS ElectroImmunot
[ Thu, Mar 08th 2012 ] - Market Wire
Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012
[ Thu, Mar 08th 2012 ] - Market Wire
Threshold Pharmaceuticals Reports Fourth Quarter .. d Year End 2011 Financial and Operational Results
[ Thu, Mar 08th 2012 ] - Market Wire
Sana Kliniken AG firma un acuerdo con Masimo para .. oluciones de supervisin de pacientes no invasivas
[ Thu, Mar 08th 2012 ] - Market Wire
Regeneron and Bayer Announce Approval of EYLEA (a .. Treatment of Wet Age-Related Macular Degeneratio
Wed, March 7, 2012
[ Wed, Mar 07th 2012 ] - Market Wire
Amylin Pharmaceuticals Announces Public Offering of Common Stock
[ Wed, Mar 07th 2012 ] - Market Wire
Resmed Inc. to Present at Upcoming Conferences
[ Wed, Mar 07th 2012 ] - Market Wire
Harwood Feffer LLP Announces Investigation of Transcend Services, Inc.
[ Wed, Mar 07th 2012 ] - Market Wire
International Drug &;; Explosives Detec .. ounces Strategic Alliance With an American Compan
[ Wed, Mar 07th 2012 ] - Market Wire
SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease
[ Wed, Mar 07th 2012 ] - Market Wire
Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial
[ Wed, Mar 07th 2012 ] - Market Wire
Prana Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease Trial
[ Wed, Mar 07th 2012 ] - Market Wire
GenVec to Release Fourth Quarter and Year-End 201 .. s and Conduct a Conference Call on March 15, 2012
[ Wed, Mar 07th 2012 ] - Market Wire
EnteroMedics to Present at the 24th Annual ROTH Capital Growth Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Discovery Labs to Hold Conference Call to Discuss FDA Approval of SURFAXIN (lucinactant)
[ Wed, Mar 07th 2012 ] - Market Wire
iBio to Present at the 24th Annual ROTH Conference on March 14
[ Wed, Mar 07th 2012 ] - Market Wire
Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Synthetic Biologics to Present at ROTH Annual Growth Stock Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Transcept Pharmaceuticals to Report Fourth Quarte .. l Results and Host Conference Call on March 14, 2
[ Wed, Mar 07th 2012 ] - Market Wire
Horizon Pharma Enters Into Exclusive Agreement Wi .. ization of LODOTRA(R) (Modified-Release Prednison
[ Wed, Mar 07th 2012 ] - Market Wire
CMS Assigns Payment to Novadaq's SPY Imaging Under OPPS
[ Wed, Mar 07th 2012 ] - Market Wire
Solta Medical Provides Update on Liposonix Launch
[ Wed, Mar 07th 2012 ] - Market Wire
The Ensign Group Acquires an Idaho Skilled Nursing Facility
[ Wed, Mar 07th 2012 ] - Market Wire
OncoSec's OMS ElectroImmunotherapy Technology Pla .. I Merkel Cell Carcinoma Clinical Trial Featured i
[ Wed, Mar 07th 2012 ] - Market Wire
Inovio Appoints Vaccine Industry Leader to its Scientific Advisory Board
Tue, March 6, 2012
[ Tue, Mar 06th 2012 ] - Market Wire
Discovery Labs Announces FDA Approval of SURFAXIN .. ) for Prevention of Respiratory Distress Syndrome
[ Tue, Mar 06th 2012 ] - Market Wire
TPI Updated Corporate Presentation at 32nd Cowen's Healthcare Conference
[ Tue, Mar 06th 2012 ] - Market Wire
PharmAthene to Host Year-End 2011 Earnings Conference Call and Webcast on Thursday, March 8, 2012
[ Tue, Mar 06th 2012 ] - Market Wire
ProMetic Secures a $2.5 Million Follow on Agreement
[ Tue, Mar 06th 2012 ] - Market Wire
Lpath Raises $9.3 Million in Equity Financing
[ Tue, Mar 06th 2012 ] - Market Wire
CareFusion To Acquire Pharmacy Automation Technology Leader
[ Tue, Mar 06th 2012 ] - Market Wire
STATS ChipPAC's Scalable 3D eWLB Solutions Delive .. t Advantages Over Substrate-Based Package-on-Pack
[ Tue, Mar 06th 2012 ] - Market Wire
Idenix Pharmaceuticals Announces Declaration of a Patent Interference by the USPTO
[ Tue, Mar 06th 2012 ] - Market Wire
Comprehensive Care Corporation Expands Contract with Nation's Largest Public Health Plan
[ Tue, Mar 06th 2012 ] - Market Wire
More Regulation Looms for the Medical Equipment and Supplies Industry
[ Tue, Mar 06th 2012 ] - Market Wire
Shares of Antares Pharma and Boston Scientific on .. l Equipment and Supplies Industry Soaring in 2012
[ Tue, Mar 06th 2012 ] - Market Wire
Verotoxin and E. coli 0157
[ Tue, Mar 06th 2012 ] - Market Wire
Titan Medical Inc. Announces Memorandum of Unders .. with Switzerland Based Clinique Generale-Beaulieu
[ Tue, Mar 06th 2012 ] - Market Wire
InspireMD Announces its 2011 Year End Financial Results
[ Tue, Mar 06th 2012 ] - Market Wire
Cytokinetics Announces That the European Medicine .. 57 Orphan Medicinal Product Designation for the T
[ Tue, Mar 06th 2012 ] - Market Wire
Rigel Announces Fourth Quarter and Year End 2011 Financial Results
[ Tue, Mar 06th 2012 ] - Market Wire
Shire to Initiate Two Phase 4 Clinical Trials to .. mine dimesylate) Capsules, (CII) to Concerta (met
[ Tue, Mar 06th 2012 ] - Market Wire
Implant Sciences Joins SOSSEC - Consortium of Lea .. rs in Security &;; Defense Technologies
[ Tue, Mar 06th 2012 ] - Market Wire
PAREXEL International to Present at Barclays Capital Healthcare Conference
[ Tue, Mar 06th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Oral Presenta .. 02 Clinical Study at the 2012 AACR Annual Meeting
Mon, March 5, 2012
[ Mon, Mar 05th 2012 ] - Market Wire
Cadence Pharmaceuticals to Host Conference Call a .. Quarter and Full Year 2011 Financial Results on M
[ Mon, Mar 05th 2012 ] - Market Wire
Major Repligen (Nasdaq: RGEN) Shareholder Files Amended 13D
[ Mon, Mar 05th 2012 ] - Market Wire
HealthSouth to Present at the Barclays Capital Global Healthcare Conference
[ Mon, Mar 05th 2012 ] - Market Wire
Gemoscan Canada Announces Appointment of Vice President, Investor Relations
[ Mon, Mar 05th 2012 ] - Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ] - Market Wire
Lilly Pledges $100,000 to American Red Cross' Tornado Disaster Relief Efforts
[ Mon, Mar 05th 2012 ] - Market Wire
BIOLASE Declares Stock Dividend for 2012 First Quarter
[ Mon, Mar 05th 2012 ] - Market Wire
30 a.m. ET
[ Mon, Mar 05th 2012 ] - Market Wire
Access Pharmaceuticals Announces Preliminary Four .. 9; MuGard Product Revenue Increases 400% Quar
[ Mon, Mar 05th 2012 ] - Market Wire
New Stem Cell Research Shows Promising Results -- Advanced Cell Tech and NeoStem Poised to Benefit
[ Mon, Mar 05th 2012 ] - Market Wire
Sequenom Announces Participation at the 24th Annual Roth OC Growth Stock Conference
[ Mon, Mar 05th 2012 ] - Market Wire
Cytokinetics Announces Fundamental Research in th .. le Activation Published in the Journal Nature Med
[ Mon, Mar 05th 2012 ] - Market Wire
BioDelivery Sciences to Present at Cowen and ROTH Conferences
[ Mon, Mar 05th 2012 ] - Market Wire
Isis Pharmaceuticals to Present at the 24th Annual ROTH Conference
[ Mon, Mar 05th 2012 ] - Market Wire
The Ensign Group Announces Acquisition of Doctors Express Franchise System
[ Mon, Mar 05th 2012 ] - Market Wire
OncoSec to Present at Cowen and ROTH Healthcare Conferences
[ Mon, Mar 05th 2012 ] - Market Wire
BioLife Solutions Commences Build-Out of Second G .. P Production Suite and Corporate Office Expansion
[ Mon, Mar 05th 2012 ] - Market Wire
Inovio Therapeutic Vaccine for Head amp;; .. ncers Induces Robust T-Cell Immune Response in Mi
[ Mon, Mar 05th 2012 ] - Market Wire
Inovio Therapeutic Vaccine for Head & Neck and Ot .. ers Induces Robust T-Cell Immune Response in Mice
[ Mon, Mar 05th 2012 ] - Market Wire
diaDexus Launches PLAC Test for Lp-PLA(2) Activity in Europe
Fri, March 2, 2012
[ Fri, Mar 02nd 2012 ] - Market Wire
Baxter Receives Marketing Authorization in Europe .. Union for VEPACEL Pre-Pandemic Influenza Vaccine
[ Fri, Mar 02nd 2012 ] - Market Wire
GTx Announces Webcast of Corporate Presentation at the Cowen and Co. Annual Health Care Conference
[ Fri, Mar 02nd 2012 ] - Market Wire
Cigna Corporation Announces Appearance at the Barclays Capital Global Healthcare Conference
[ Fri, Mar 02nd 2012 ] - Market Wire
Boston Therapeutics to Be Quoted as BTHE on the OTC Bulletin Board
[ Fri, Mar 02nd 2012 ] - Market Wire
Alere to Attend the Raymond James amp;; As .. stitutional Investors Conference on March 6, 2012
[ Fri, Mar 02nd 2012 ] - Market Wire
Warnex Extends Maturity Date of its Outstanding D .. entures and Provides Update on its Listing Status
[ Fri, Mar 02nd 2012 ] - Market Wire
Abbott's STARLIMS Business Acquires Distribution Partners to Build International Presence
[ Fri, Mar 02nd 2012 ] - Market Wire
Syneron Closes Acquisition of Ultrashape Ltd.
[ Fri, Mar 02nd 2012 ] - Market Wire
Amerigroup Expands Operations in Texas
[ Fri, Mar 02nd 2012 ] - Market Wire
Arena Pharmaceuticals Files European Marketing Au .. ion Application for Lorcaserin for Weight Control
[ Fri, Mar 02nd 2012 ] - Market Wire
Orexigen Therapeutics Schedules March 8, 2012 Web .. Results for the Fourth Quarter and Year Ended Dec
[ Fri, Mar 02nd 2012 ] - Market Wire
ProMetic Announces Changes to Its Board of Directors
[ Fri, Mar 02nd 2012 ] - Market Wire
Given Imaging Supports Fight Against Colorectal Cancer
[ Fri, Mar 02nd 2012 ] - Market Wire
SciClone Announces Results of Interim Analysis of Phase 2 SCV-07 Oral Mucositis Trial
[ Fri, Mar 02nd 2012 ] - Market Wire
Media Advisory - Oncolytics Biotech Inc. to Prese .. en and Company 32nd Annual Health Care Conference
[ Fri, Mar 02nd 2012 ] - Market Wire
Delcath to Conduct Conference Call to Discuss Full Year 2011 Results and Recent Corporate Progress
[ Fri, Mar 02nd 2012 ] - Market Wire
IRIDEX to Present at Upcoming Investment Conferences
[ Fri, Mar 02nd 2012 ] - Market Wire
NEXAFED(TM) Pseudoephedrine Tablets Disrupt Methamphetamine Production
[ Fri, Mar 02nd 2012 ] - Market Wire
Concord Medical to Report Fourth Quarter and Full Year 2011 Financial Results on March 21, 2012
Thu, March 1, 2012
[ Thu, Mar 01st 2012 ] - Market Wire
Idenix Pharmaceuticals Elects Thomas Hodgson as C .. Appoints Michael Wyzga to Its Board of Directors
[ Thu, Mar 01st 2012 ] - Market Wire
IMRIS reports fourth quarter and annual 2011 financial results
[ Thu, Mar 01st 2012 ] - Market Wire
Peregrine to Report Third Quarter Fiscal Year 2012 Financial Results After Market on March 9, 2012
[ Thu, Mar 01st 2012 ] - Market Wire
Helix BioPharma Corp. Announces L-DOS47 Scientifi .. the Second Annual IBC Conference on Analytical Te
[ Thu, Mar 01st 2012 ] - Market Wire
Abbott to Build Nutrition Manufacturing Facility in Ohio
[ Thu, Mar 01st 2012 ] - Market Wire
Southern Home Medical Provides Corporate Overview for Shareholders and Financial Industry
[ Thu, Mar 01st 2012 ] - Market Wire
Tibet Pharmaceuticals, Inc. Announces Receipt of .. g Privatequot;; Proposal at $3.00 Per Shar
[ Thu, Mar 01st 2012 ] - Market Wire
Novelos Therapeutics and Academic Collaborators H .. pted for Presentation at 2012 AACR Annual Meeting
[ Thu, Mar 01st 2012 ] - Market Wire
Cantel Medical Corp. to Hold Conference Call to D .. lts for Its Second Quarter Ended January 31, 2012
[ Thu, Mar 01st 2012 ] - Market Wire
Boston Scientific Announces Launch of PROMUS Elementa" Platinum Chromium Stent System in Japan
[ Thu, Mar 01st 2012 ] - Market Wire
Revealing an Innovative Corporate Structure Dedicated to Redefining Healthcare Value
[ Thu, Mar 01st 2012 ] - Market Wire
Hamilton Thorne Expands Distribution Partnership .. e and Optical Systems Producer Leica Microsystems
[ Thu, Mar 01st 2012 ] - Market Wire
Peregrine Announces Seven Abstracts Accepted for Presentation at AACR 2012 Annual Meeting
[ Thu, Mar 01st 2012 ] - Market Wire
Amica Mature Lifestyles Increases Ownership in Amica at Dundas
[ Thu, Mar 01st 2012 ] - Market Wire
Trimel Pharmaceuticals Corporation to Report Fina .. 11 and Host a Conference Call to Update Investors
[ Thu, Mar 01st 2012 ] - Market Wire
Digirad Corporation Board of Directors Adopts Strengthened Charter and Policies
[ Thu, Mar 01st 2012 ] - Market Wire
Novadaq Announces NASDAQ Listing
[ Thu, Mar 01st 2012 ] - Market Wire
Omeros to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Thu, Mar 01st 2012 ] - Market Wire
Herborium Group to Begin Commercialization of its .. roducts With Aggressive Plans to Take a Bite of a
Wed, February 29, 2012
[ Wed, Feb 29th 2012 ] - Market Wire
AMI Research Initiates Analyst Coverage on Pressure BioSciences, Inc.;; BUY
[ Wed, Feb 29th 2012 ] - Market Wire
Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Thera Max Cold and Flu Brand Receives Great Benef .. Ongoing Social Media Marketing Awareness Program
[ Wed, Feb 29th 2012 ] - Market Wire
Celsion to Present at Upcoming Investor Conferences in March 2012
[ Wed, Feb 29th 2012 ] - Market Wire
Hi-Tech Pharmacal Receives Final Approval for Levetiracetam Oral Solution
[ Wed, Feb 29th 2012 ] - Market Wire
Avanir Pharmaceuticals and Concert Pharmaceutical .. to Develop and Commercialize Deuterium-modified D
[ Wed, Feb 29th 2012 ] - Market Wire
AMRI Expands Quality Control Leadership to Support Future Growth
[ Wed, Feb 29th 2012 ] - Market Wire
Marina Biotech Presents Advances in Oral Delivery .. of Nucleic Acids at AsiaTIDES Conference in Tokyo
[ Wed, Feb 29th 2012 ] - Market Wire
Mylan Launches First Equivalent Product to Lexapro Tablets
[ Wed, Feb 29th 2012 ] - Market Wire
Synergetics USA Announces Conference Call to Review Second Quarter of Fiscal Year 2012 Results
[ Wed, Feb 29th 2012 ] - Market Wire
Dyax Announces Appointment of Dr. Burt Adelman as Chief Medical Officer
[ Wed, Feb 29th 2012 ] - Market Wire
Horizon Pharma Announces $50.8 Million Private Placement
[ Wed, Feb 29th 2012 ] - Market Wire
Arrowhead Announces Patent Issuance Covering siRNA Inhibitors of HIF-2a (EPAS1)
[ Wed, Feb 29th 2012 ] - Market Wire
BioLineRx Announces Receipt of Notice of Allowanc .. ing BCM (BL-1040), a Novel Medical Device for Pre
[ Wed, Feb 29th 2012 ] - Market Wire
Biogen Idec levert aanvraag in bij FDA voor goedk .. ale BG-12 voor behandeling van Multiple Sclerosis
[ Wed, Feb 29th 2012 ] - Market Wire
Columbia Laboratories Will Present March 5th at Cowen and Company Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
ProMetic Finalizes Its Agreement With Celgene Corporation
[ Wed, Feb 29th 2012 ] - Market Wire
OncoSec's OMS ElectroOncology Technology Platform .. n Medical Device amp;; Diagnostic Industry
[ Wed, Feb 29th 2012 ] - Market Wire
Auxilium Partners With the National Organization for Rare Disorders to Observe Rare Disease Day
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Ironwood Pharmaceuticals Provides Fourth Quarter 2011 Investor Update
[ Tue, Feb 28th 2012 ] - Market Wire
Quest Diagnostics to Speak at the 2012 RBC Capital Markets Healthcare Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Alere to Acquire eScreen, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
Cigna Corporation Announces Appearance at the Cowen 32nd Annual Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Johnson & Johnson to Participate in Cowen and Company 32nd Annual Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Johnson amp;; Johnson to Participate in Co .. en and Company 32nd Annual Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Teva to Present at the 2012 RBC Capital Marketsa Global Healthcare Conference
[ Tue, Feb 28th 2012 ] - Market Wire
AdCare Health Systems to Present at the ROTH Capi .. Partners 24th Annual Conference on March 12, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
AVI BioPharma Announces FDA Approval to Proceed W .. Dosing of AVI-6003 for Treatment of Marburg Virus
[ Tue, Feb 28th 2012 ] - Market Wire
ARIAD Reports 2011 Financial Results and Outlines .. Development and Commercialization Plans for 2012
[ Tue, Feb 28th 2012 ] - Market Wire
POZEN Reports Fourth Quarter & Year End 2011 Results
[ Tue, Feb 28th 2012 ] - Market Wire
UnitedHealthcare to Strengthen Service to Florida .. of Preferred Care Partners and Medica Healthcare
[ Tue, Feb 28th 2012 ] - Market Wire
Aviation Security in China Continues to Purchase .. lant Sciences' Explosives Trace Detection Devices
[ Tue, Feb 28th 2012 ] - Market Wire
BioDelivery Sciences and FDA Reach Agreement on BNX Development Plan
[ Tue, Feb 28th 2012 ] - Market Wire
ICON Acquires PriceSpective
[ Tue, Feb 28th 2012 ] - Market Wire
Delcath to Present at 24th Annual Roth Growth Stock Conference on March 12
[ Tue, Feb 28th 2012 ] - Market Wire
OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma
[ Tue, Feb 28th 2012 ] - Market Wire
Astex Pharmaceuticals to Announce 2011 Fourth Qua .. r and Year-End Financial Results on March 5, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Inovio Pharmaceuticals to Present at Cowen and ROTH Investor Conferences
Mon, February 27, 2012
[ Mon, Feb 27th 2012 ] - Market Wire
Forest Laboratories, Inc. and Gedeon Richter Plc. .. ositive Phase III Trials with the Investigational
[ Mon, Feb 27th 2012 ] - Market Wire
NYSE, NASDAQ and OTC Markets Listed Companies Joi .. Live, March 1st at RetailInvestorConferences.com
[ Mon, Feb 27th 2012 ] - Market Wire
Prestige Brands Holdings, Inc. Adopts Stockholder Rights Plan
[ Mon, Feb 27th 2012 ] - Market Wire
Pro-Dex, Inc. Announces the Sale Of Its Motor Business
[ Mon, Feb 27th 2012 ] - Market Wire
BioLineRx Ltd. Announces Closing of $15 Million Private Placement to Institutional Investors
[ Mon, Feb 27th 2012 ] - Market Wire
Aetna Recognized for LGBT Equality for Tenth Year in a Row
[ Mon, Feb 27th 2012 ] - Market Wire
Ironwood Pharmaceuticals to Present at Cowen and Company Annual Health Care Conference
[ Mon, Feb 27th 2012 ] - Market Wire
Exactech Announces $100 Million Long Term Syndicated Credit Facility
[ Mon, Feb 27th 2012 ] - Market Wire
Graymark Healthcare to Present at the ROTH Capita .. Partners 24th Annual Conference on March 14, 2012
[ Mon, Feb 27th 2012 ] - Market Wire
Cempra, Inc. Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares

Isis Pharmaceuticals to Present at the 24th Annual ROTH Conference


//health-fitness.news-articles.net/content/2012/ .. -present-at-the-24th-annual-roth-conference.html
Published in Health and Fitness on Monday, March 5th 2012 at 4:45 GMT by Market Wire   Print publication without navigation


Isis Pharmaceuticals to Present at the 24th Annual ROTH Conference -- CARLSBAD, Calif., March 5, 2012 /PRNewswire/ --

Isis Pharmaceuticals to Present at the 24th Annual ROTH Conference

[ ]

CARLSBAD, Calif., March 5, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: [ ISIS ]), the leader in antisense therapeutics, today announced that management will present a company overview at ROTH's 24th Annual OC Growth Stock Conference on Monday, March 12, 2012 at 9:30 a.m. PT at the Ritz-Carlton Laguna Niguel.  

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, [ www.isispharm.com ].  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 26 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at [ www.isispharm.com ].

SOURCE Isis Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.isispharm.com ]


Publication Contributing Sources